speb/financial-data huggingface dataset:
BMET.V income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 23125.00
BMET.V balance_sheet (quarterly, 2025-03-31) — Invested Capital: 35929235.00
BMET.V cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -432154.00
BMET.V balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 467220.00
BMET.V balance_sheet (quarterly, 2025-03-31) — Investments In Other Ventures Under Equity Method: 467220.00
BMET.V cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
BMET.V balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 4356378.00
BMET.V balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 4356378.00
BMET.V balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 467220.00
BMET.V balance_sheet (quarterly, 2025-03-31) — Net Debt: 10474767.00
BMET.V cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -61165.00
BMET.V income_statement (quarterly, 2025-03-31) — Net Income: -539941.00
BMET.V income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -539941.00
BMET.V income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -539941.00
BMET.V income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -539941.00
BMET.V income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -539941.00
BMET.V cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -539941.00
BMET.V income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -539941.00
BMET.V income_statement (quarterly, 2025-03-31) — Net Interest Income: -230633.00
BMET.V cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 0.00
BMET.V income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -230633.00
BMET.V cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -432154.00
BMET.V balance_sheet (quarterly, 2025-03-31) — Net PPE: 33099365.00
BMET.V cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 0.00
BMET.V cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: 0.00
BMET.V balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 23444466.00
BMET.V balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 354666.00
BMET.V income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -279838.00
BMET.V income_statement (quarterly, 2025-03-31) — Normalized Income: -533596.00
BMET.V cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -329316.00
BMET.V cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -56609.00
BMET.V income_statement (quarterly, 2025-03-31) — Operating Income: -302963.00
BMET.V income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
BMET.V balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 22884714.00
BMET.V balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 8128391.00
BMET.V balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 4319220.00
BMET.V balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 1747194.00
BMET.V income_statement (quarterly, 2025-03-31) — Other Gand A: 59503.00
BMET.V income_statement (quarterly, 2025-03-31) — Other Income Expense: -6345.00
BMET.V cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 253758.00
BMET.V income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 33028.00
BMET.V balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 46000.00
BMET.V balance_sheet (quarterly, 2025-03-31) — Payables: 91983.00
BMET.V balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 91983.00
BMET.V balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 36644.00
BMET.V income_statement (quarterly, 2025-03-31) — Pretax Income: -539941.00
BMET.V balance_sheet (quarterly, 2025-03-31) — Receivables: 36282.00
BMET.V balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -28550776.00
BMET.V income_statement (quarterly, 2025-03-31) — Salaries And Wages: 206194.00
BMET.V cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 0.00
BMET.V income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 4238.00
BMET.V income_statement (quarterly, 2025-03-31) — Selling General And Administration: 269935.00
BMET.V balance_sheet (quarterly, 2025-03-31) — Share Issued: 22884714.00
BMET.V cash_flow (quarterly, 2025-03-31) — Short Term Debt Issuance: 0.00
BMET.V cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 0.00
BMET.V balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 23444466.00
BMET.V balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 23444466.00
BMET.V income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
BMET.V income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
BMET.V balance_sheet (quarterly, 2025-03-31) — Total Assets: 36050178.00
BMET.V balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 27800844.00
BMET.V balance_sheet (quarterly, 2025-03-31) — Total Debt: 12484769.00
BMET.V balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 23444466.00
BMET.V income_statement (quarterly, 2025-03-31) — Total Expenses: 302963.00
BMET.V balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 12605712.00
BMET.V balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 33921251.00
BMET.V balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 4385338.00
BMET.V income_statement (quarterly, 2025-03-31) — Total Unusual Items: -6345.00
BMET.V income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -6345.00
BMET.V balance_sheet (quarterly, 2025-03-31) — Working Capital: -6091446.00
BMET.V income_statement (quarterly, 2025-06-30) — +Operating Expense: 330854.00
BMET.V income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 186951.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 18685.00
BMET.V income_statement (quarterly, 2025-06-30) — Basic Average Shares: 22238851.00
BMET.V income_statement (quarterly, 2025-06-30) — Basic EPS: -0.80
BMET.V cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 2010002.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Capital Stock: 45928828.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 1005193.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 1051193.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Cash Financial: 1005193.00
BMET.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 0.00
BMET.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -623437.00
BMET.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -350666.00
BMET.V cash_flow (quarterly, 2025-06-30) — Change In Payable: -43920.00
BMET.V cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -43920.00
BMET.V cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 17077.00
BMET.V cash_flow (quarterly, 2025-06-30) — Change In Receivables: 17597.00
BMET.V cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -9246.00
BMET.V cash_flow (quarterly, 2025-06-30) — Changes In Cash: -974104.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Common Stock: 45928828.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 6049084.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Current Assets: 1089445.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 186951.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 36382.00
BMET.V income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 22238851.00
BMET.V income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.80
BMET.V income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -17791081.00
BMET.V income_statement (quarterly, 2025-06-30) — EBIT: -17537003.00
BMET.V income_statement (quarterly, 2025-06-30) — EBITDA: -17537003.00
BMET.V cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -30705.00
BMET.V cash_flow (quarterly, 2025-06-30) — End Cash Position: 1005193.00
BMET.V cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 0.00
BMET.V cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -350666.00
BMET.V cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 7422.00
BMET.V income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 358634.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 4714920.00
BMET.V income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 295183.00
BMET.V income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: 17580142.00
BMET.V income_statement (quarterly, 2025-06-30) — Interest Expense: 254079.00
BMET.V income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 254079.00
BMET.V income_statement (quarterly, 2025-06-30) — Interest Income: 15359.00
BMET.V income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 15359.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Invested Capital: 18365245.00
BMET.V cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -623438.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 862920.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Investments In Other Ventures Under Equity Method: 862920.00
BMET.V cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 0.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 12316161.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 12316161.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 862920.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Net Debt: 11310968.00
BMET.V cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: -391982.00
BMET.V income_statement (quarterly, 2025-06-30) — Net Income: -17791081.00
BMET.V income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -17791081.00
BMET.V income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -17791082.00
BMET.V income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -17791081.00
BMET.V income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -17791081.00
BMET.V cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -17791081.00
BMET.V income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -17791082.00
BMET.V income_statement (quarterly, 2025-06-30) — Net Interest Income: -238720.00
BMET.V cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 0.00
BMET.V income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -238720.00
BMET.V cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -1062812.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Net PPE: 16571225.00
BMET.V cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: 439374.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 6049084.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Non Current Prepaid Assets: 64987.00
BMET.V income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -315495.00
BMET.V income_statement (quarterly, 2025-06-30) — Normalized Income: -569573.00
BMET.V cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -350666.00
BMET.V cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -384560.00
BMET.V income_statement (quarterly, 2025-06-30) — Operating Income: -330854.00
BMET.V income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 22884714.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 4714920.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: 1747194.00
BMET.V income_statement (quarterly, 2025-06-30) — Other Gand A: 91317.00
BMET.V income_statement (quarterly, 2025-06-30) — Other Income Expense: -17221508.00
BMET.V cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 254079.00
BMET.V income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 32223.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 46000.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Payables: 186951.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 186951.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 19567.00
BMET.V income_statement (quarterly, 2025-06-30) — Pretax Income: -17791082.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Receivables: 18685.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -46341858.00
BMET.V income_statement (quarterly, 2025-06-30) — Salaries And Wages: 203866.00
BMET.V cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 439374.00
BMET.V income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 3448.00
BMET.V income_statement (quarterly, 2025-06-30) — Selling General And Administration: 298631.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Share Issued: 22884714.00
BMET.V income_statement (quarterly, 2025-06-30) — Special Income Charges: -17580142.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 6049084.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 6049084.00
BMET.V income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
BMET.V income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Total Assets: 18588578.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 18365245.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Total Debt: 12316161.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 6049084.00
BMET.V income_statement (quarterly, 2025-06-30) — Total Expenses: 330854.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 12539494.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 17499132.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 12352543.00
BMET.V income_statement (quarterly, 2025-06-30) — Total Unusual Items: -17221508.00
BMET.V income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -17221508.00
BMET.V balance_sheet (quarterly, 2025-06-30) — Working Capital: 902494.00
BMET.V income_statement (quarterly, 2025-09-30) — +Operating Expense: 337981.00
BMET.V income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 102671.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 19993.00
BMET.V cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 0.00
BMET.V income_statement (quarterly, 2025-09-30) — Basic Average Shares: 22884714.00
BMET.V income_statement (quarterly, 2025-09-30) — Basic EPS: 0.00
BMET.V cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 1005193.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Capital Stock: 45928828.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 1551691.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1597691.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Cash Financial: 1551691.00
BMET.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 0.00
BMET.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 863400.00
BMET.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -316903.00
BMET.V cash_flow (quarterly, 2025-09-30) — Change In Payable: 56328.00
BMET.V cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 56328.00
BMET.V cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -44539.00
BMET.V cash_flow (quarterly, 2025-09-30) — Change In Receivables: -1308.00
BMET.V cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 10481.00
BMET.V cash_flow (quarterly, 2025-09-30) — Changes In Cash: 546498.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Common Stock: 45928828.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 5537869.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Current Assets: 1681790.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 102671.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Derivative Product Liabilities: 42905.00
BMET.V income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 22884714.00
BMET.V income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.00
BMET.V income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 12522.00
BMET.V income_statement (quarterly, 2025-09-30) — EBIT: 300507.00
BMET.V income_statement (quarterly, 2025-09-30) — EBITDA: 300507.00
BMET.V cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 0.00
BMET.V cash_flow (quarterly, 2025-09-30) — End Cash Position: 1551691.00
BMET.V cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 0.00
BMET.V cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -316903.00
BMET.V cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -792368.00
BMET.V income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 632169.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 4191184.00
BMET.V income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 307201.00
BMET.V income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 0.00
BMET.V income_statement (quarterly, 2025-09-30) — Interest Expense: 287986.00
BMET.V income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 287986.00
BMET.V income_statement (quarterly, 2025-09-30) — Interest Income: 6319.00
BMET.V income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 6319.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Invested Capital: 18302033.00
BMET.V cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 863401.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 0.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Investments In Other Ventures Under Equity Method: 0.00
BMET.V cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 12764164.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 12764164.00
BMET.V cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 0.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 0.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Net Debt: 11212473.00
BMET.V cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: 160017.00
BMET.V income_statement (quarterly, 2025-09-30) — Net Income: 12522.00
BMET.V income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 12522.00
BMET.V income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 12521.00
BMET.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 12522.00
BMET.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 12522.00
BMET.V cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 12522.00
BMET.V income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 12521.00
BMET.V income_statement (quarterly, 2025-09-30) — Net Interest Income: -281667.00
BMET.V cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 0.00
BMET.V cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 0.00
BMET.V income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -281667.00
BMET.V cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -270215.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Net PPE: 16675442.00
BMET.V cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 0.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 5537869.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Non Current Prepaid Assets: 90378.00
BMET.V income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -331662.00
BMET.V income_statement (quarterly, 2025-09-30) — Normalized Income: -524821.65
BMET.V cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -316903.00
BMET.V cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -632351.00
BMET.V income_statement (quarterly, 2025-09-30) — Operating Income: -337981.00
BMET.V income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 22884714.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 4191184.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 1747194.00
BMET.V income_statement (quarterly, 2025-09-30) — Other Gand A: 68298.00
BMET.V income_statement (quarterly, 2025-09-30) — Other Income Expense: 632169.00
BMET.V cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 287986.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 1.00
BMET.V income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 30780.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 46000.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Payables: 102671.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 102671.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 64106.00
BMET.V income_statement (quarterly, 2025-09-30) — Pretax Income: 12521.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Receivables: 19993.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -46329337.00
BMET.V income_statement (quarterly, 2025-09-30) — Salaries And Wages: 238903.00
BMET.V cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 0.00
BMET.V income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 0.00
BMET.V income_statement (quarterly, 2025-09-30) — Selling General And Administration: 307201.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Share Issued: 22884714.00
BMET.V income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 5537869.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 5537869.00
BMET.V income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 94825.35
BMET.V income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.15
BMET.V balance_sheet (quarterly, 2025-09-30) — Total Assets: 18447610.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 18302033.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Total Debt: 12764164.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 5537869.00
BMET.V income_statement (quarterly, 2025-09-30) — Total Expenses: 337981.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 12909741.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 16765820.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 12807070.00
BMET.V income_statement (quarterly, 2025-09-30) — Total Unusual Items: 632169.00
BMET.V income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 632169.00
BMET.V balance_sheet (quarterly, 2025-09-30) — Working Capital: 1579119.00
BMET.V income_statement (annual, 2025-12-31) — +Operating Expense: 1392831.00
BMET.V income_statement (quarterly, 2025-12-31) — +Operating Expense: 421035.00
BMET.V income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
BMET.V income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
BMET.V balance_sheet (annual, 2025-12-31) — Accounts Payable: 180562.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 180562.00
BMET.V balance_sheet (annual, 2025-12-31) — Accounts Receivable: 32157.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 32157.00
BMET.V cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 29731483.00
BMET.V cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 12151341.00
BMET.V income_statement (annual, 2025-12-31) — Basic Average Shares: 22578286.00
BMET.V income_statement (annual, 2025-12-31) — Basic EPS: -1.10
BMET.V cash_flow (annual, 2025-12-31) — Beginning Cash Position: 2710057.00
BMET.V cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 1551691.00
BMET.V balance_sheet (annual, 2025-12-31) — Capital Stock: 55323869.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Capital Stock: 55323869.00
BMET.V balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 1883541.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 1883541.00
BMET.V balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1929541.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1929541.00
BMET.V balance_sheet (annual, 2025-12-31) — Cash Financial: 1883541.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Cash Financial: 1883541.00
BMET.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 766405.00
BMET.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 766405.00
BMET.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -383822.00
BMET.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -191631.00
BMET.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -1163108.00
BMET.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -166223.00
BMET.V cash_flow (annual, 2025-12-31) — Change In Payable: 55770.00
BMET.V cash_flow (quarterly, 2025-12-31) — Change In Payable: 38509.00
BMET.V cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 55770.00
BMET.V cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 38509.00
BMET.V cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -4566.00
BMET.V cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 15798.00
BMET.V cash_flow (annual, 2025-12-31) — Change In Receivables: 5650.00
BMET.V cash_flow (quarterly, 2025-12-31) — Change In Receivables: -12164.00
BMET.V cash_flow (annual, 2025-12-31) — Change In Working Capital: 56854.00
BMET.V cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 42143.00
BMET.V cash_flow (annual, 2025-12-31) — Changes In Cash: -780525.00
BMET.V cash_flow (quarterly, 2025-12-31) — Changes In Cash: 408551.00
BMET.V balance_sheet (annual, 2025-12-31) — Common Stock: 55323869.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Common Stock: 55323869.00
BMET.V balance_sheet (annual, 2025-12-31) — Common Stock Equity: 6674936.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 6674936.00
BMET.V cash_flow (annual, 2025-12-31) — Common Stock Issuance: 848840.00
BMET.V cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 848840.00
BMET.V cash_flow (annual, 2025-12-31) — Common Stock Payments: -82435.00
BMET.V cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -82435.00
BMET.V balance_sheet (annual, 2025-12-31) — Current Assets: 2010006.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Current Assets: 2010006.00
BMET.V balance_sheet (annual, 2025-12-31) — Current Liabilities: 180562.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 180562.00
BMET.V balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 0.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 0.00
BMET.V income_statement (annual, 2025-12-31) — Diluted Average Shares: 22578286.00
BMET.V income_statement (annual, 2025-12-31) — Diluted EPS: -1.10
BMET.V income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -24836115.00
BMET.V income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -6517615.00
BMET.V income_statement (annual, 2025-12-31) — EBIT: -23752689.00
BMET.V income_statement (quarterly, 2025-12-31) — EBIT: -6230010.00
BMET.V income_statement (annual, 2025-12-31) — EBITDA: -23752689.00
BMET.V income_statement (quarterly, 2025-12-31) — EBITDA: -6230010.00
BMET.V cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -45991.00
BMET.V cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -76701.00
BMET.V cash_flow (annual, 2025-12-31) — End Cash Position: 1883541.00
BMET.V cash_flow (quarterly, 2025-12-31) — End Cash Position: 1883541.00
BMET.V cash_flow (annual, 2025-12-31) — Financing Cash Flow: 766405.00
BMET.V cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 766405.00
BMET.V cash_flow (annual, 2025-12-31) — Free Cash Flow: -1163108.00
BMET.V cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -166223.00
BMET.V cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -823295.00
BMET.V cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -42905.00
BMET.V income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 1127058.00
BMET.V income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 142601.00
BMET.V balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 4198018.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 4198018.00
BMET.V income_statement (annual, 2025-12-31) — General And Administrative Expense: 1225578.00
BMET.V income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 357499.00
BMET.V income_statement (annual, 2025-12-31) — Interest Expense: 1083426.00
BMET.V income_statement (quarterly, 2025-12-31) — Interest Expense: 287603.00
BMET.V income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 1083426.00
BMET.V income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 287603.00
BMET.V income_statement (annual, 2025-12-31) — Interest Income: 57220.00
BMET.V income_statement (quarterly, 2025-12-31) — Interest Income: 12418.00
BMET.V income_statement (annual, 2025-12-31) — Interest Income Non Operating: 57220.00
BMET.V income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 12418.00
BMET.V balance_sheet (annual, 2025-12-31) — Invested Capital: 6674936.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Invested Capital: 6674936.00
BMET.V cash_flow (annual, 2025-12-31) — Investing Cash Flow: -383822.00
BMET.V cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -191631.00
BMET.V balance_sheet (annual, 2025-12-31) — Investments And Advances: 0.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 0.00
BMET.V balance_sheet (annual, 2025-12-31) — Investments In Other Ventures Under Equity Method: 0.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Investments In Other Ventures Under Equity Method: 0.00
BMET.V cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 848840.00
BMET.V cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 848840.00
BMET.V cash_flow (annual, 2025-12-31) — Issuance Of Debt: 0.00
BMET.V cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
BMET.V cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 0.00
BMET.V cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
BMET.V balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 0.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 0.00
BMET.V cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 766405.00
BMET.V cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 766405.00
BMET.V cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -318312.00
BMET.V cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -25182.00
BMET.V income_statement (annual, 2025-12-31) — Net Income: -24836115.00
BMET.V income_statement (quarterly, 2025-12-31) — Net Income: -6517615.00
BMET.V income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -24836115.00
BMET.V income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -6517615.00
BMET.V income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -24836115.00
BMET.V income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -6517613.00
BMET.V income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -24836115.00
BMET.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -6517615.00
BMET.V income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -24836115.00
BMET.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -6517615.00
BMET.V cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -24836115.00
BMET.V cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -6517615.00
BMET.V income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -24836115.00
BMET.V income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -6517613.00
BMET.V income_statement (annual, 2025-12-31) — Net Interest Income: -1026206.00
BMET.V income_statement (quarterly, 2025-12-31) — Net Interest Income: -275185.00
BMET.V cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 1133616.00
BMET.V cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 0.00
BMET.V cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
BMET.V cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
BMET.V cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 0.00
BMET.V cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 0.00
BMET.V income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -1026206.00
BMET.V income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -275185.00
BMET.V cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -1956812.00
BMET.V cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -191631.00
BMET.V balance_sheet (annual, 2025-12-31) — Net PPE: 4823017.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Net PPE: 4823017.00
BMET.V cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: 439374.00
BMET.V cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 0.00
BMET.V balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 6674936.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 6674936.00
BMET.V balance_sheet (annual, 2025-12-31) — Non Current Prepaid Assets: 22475.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Non Current Prepaid Assets: 22475.00
BMET.V income_statement (annual, 2025-12-31) — Normalized EBITDA: -1216706.00
BMET.V income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -289712.00
BMET.V income_statement (annual, 2025-12-31) — Normalized Income: -2300132.00
BMET.V income_statement (quarterly, 2025-12-31) — Normalized Income: -577317.00
BMET.V cash_flow (annual, 2025-12-31) — Operating Cash Flow: -1163108.00
BMET.V cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -166223.00
BMET.V cash_flow (annual, 2025-12-31) — Operating Gains Losses: -7210049.00
BMET.V cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -6136529.00
BMET.V income_statement (annual, 2025-12-31) — Operating Income: -1392831.00
BMET.V income_statement (quarterly, 2025-12-31) — Operating Income: -421035.00
BMET.V income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
BMET.V income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
BMET.V balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 29442360.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 29442360.00
BMET.V balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 4198018.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 4198018.00
BMET.V income_statement (annual, 2025-12-31) — Other Gand A: 356440.00
BMET.V income_statement (quarterly, 2025-12-31) — Other Gand A: 137324.00
BMET.V income_statement (annual, 2025-12-31) — Other Income Expense: -22417078.00
BMET.V income_statement (quarterly, 2025-12-31) — Other Income Expense: -5821393.00
BMET.V cash_flow (annual, 2025-12-31) — Other Non Cash Items: 1083426.00
BMET.V cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 287603.00
BMET.V income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 118905.00
BMET.V income_statement (annual, 2025-12-31) — Other Operating Expenses: 146652.00
BMET.V income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 50621.00
BMET.V balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 46000.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 46000.00
BMET.V income_statement (annual, 2025-12-31) — Other Special Charges: -6068442.00
BMET.V balance_sheet (annual, 2025-12-31) — Payables: 180562.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Payables: 180562.00
BMET.V balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 180562.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 180562.00
BMET.V balance_sheet (annual, 2025-12-31) — Prepaid Assets: 48308.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 48308.00
BMET.V income_statement (annual, 2025-12-31) — Pretax Income: -24836115.00
BMET.V income_statement (quarterly, 2025-12-31) — Pretax Income: -6517613.00
BMET.V balance_sheet (annual, 2025-12-31) — Receivables: 32157.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Receivables: 32157.00
BMET.V cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -82435.00
BMET.V cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -82435.00
BMET.V balance_sheet (annual, 2025-12-31) — Retained Earnings: -52846951.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -52846951.00
BMET.V income_statement (annual, 2025-12-31) — Salaries And Wages: 869138.00
BMET.V income_statement (quarterly, 2025-12-31) — Salaries And Wages: 220175.00
BMET.V cash_flow (annual, 2025-12-31) — Sale Of Investment: 1133616.00
BMET.V cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 0.00
BMET.V cash_flow (annual, 2025-12-31) — Sale Of PPE: 439374.00
BMET.V cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 0.00
BMET.V income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 20601.00
BMET.V income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 12915.00
BMET.V income_statement (annual, 2025-12-31) — Selling General And Administration: 1246179.00
BMET.V income_statement (quarterly, 2025-12-31) — Selling General And Administration: 370414.00
BMET.V balance_sheet (annual, 2025-12-31) — Share Issued: 29442360.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Share Issued: 29442360.00
BMET.V income_statement (annual, 2025-12-31) — Special Income Charges: -23663041.00
BMET.V income_statement (quarterly, 2025-12-31) — Special Income Charges: -6082899.00
BMET.V cash_flow (annual, 2025-12-31) — Stock Based Compensation: 11293.00
BMET.V cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 6834.00
BMET.V balance_sheet (annual, 2025-12-31) — Stockholders Equity: 6674936.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 6674936.00
BMET.V balance_sheet (annual, 2025-12-31) — Tangible Book Value: 6674936.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 6674936.00
BMET.V income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
BMET.V income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
BMET.V income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
BMET.V income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
BMET.V balance_sheet (annual, 2025-12-31) — Total Assets: 6855498.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Total Assets: 6855498.00
BMET.V balance_sheet (annual, 2025-12-31) — Total Capitalization: 6674936.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 6674936.00
BMET.V balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 6674936.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 6674936.00
BMET.V income_statement (annual, 2025-12-31) — Total Expenses: 1392831.00
BMET.V income_statement (quarterly, 2025-12-31) — Total Expenses: 421035.00
BMET.V balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 180562.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 180562.00
BMET.V balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 4845492.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 4845492.00
BMET.V balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
BMET.V income_statement (annual, 2025-12-31) — Total Unusual Items: -22535983.00
BMET.V income_statement (quarterly, 2025-12-31) — Total Unusual Items: -5940298.00
BMET.V income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -22535983.00
BMET.V income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -5940298.00
BMET.V balance_sheet (annual, 2025-12-31) — Working Capital: 1829444.00
BMET.V balance_sheet (quarterly, 2025-12-31) — Working Capital: 1829444.00
BMET.V income_statement (annual, 2025-12-31) — Write Off: 29731483.00
BMET.V income_statement (quarterly, 2026-03-31) — +Operating Expense: 335350.00
BMET.V income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
BMET.V balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 179058.00
BMET.V balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 32717.00
BMET.V income_statement (quarterly, 2026-03-31) — Basic Average Shares: 29442363.00
BMET.V income_statement (quarterly, 2026-03-31) — Basic EPS: -0.10
BMET.V cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 1883541.00
BMET.V balance_sheet (quarterly, 2026-03-31) — Capital Stock: 55323869.00
BMET.V balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1584718.00
BMET.V balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1630718.00
BMET.V balance_sheet (quarterly, 2026-03-31) — Cash Financial: 1584718.00
BMET.V cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -36403.00
BMET.V cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -258906.00
BMET.V cash_flow (quarterly, 2026-03-31) — Change In Payable: -16037.00
BMET.V cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -16037.00
BMET.V cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 10603.00
BMET.V cash_flow (quarterly, 2026-03-31) — Change In Receivables: -560.00
BMET.V cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -5994.00
BMET.V cash_flow (quarterly, 2026-03-31) — Changes In Cash: -295310.00
BMET.V balance_sheet (quarterly, 2026-03-31) — Common Stock: 55323869.00
BMET.V balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 6418511.00
BMET.V balance_sheet (quarterly, 2026-03-31) — Current Assets: 1701140.00
BMET.V balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 179058.00
BMET.V income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 29442363.00
BMET.V income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.10
BMET.V income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -258021.00
BMET.V income_statement (quarterly, 2026-03-31) — EBIT: -258022.00
BMET.V income_statement (quarterly, 2026-03-31) — EBITDA: -258022.00
BMET.V cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -3513.00
BMET.V cash_flow (quarterly, 2026-03-31) — End Cash Position: 1584718.00
BMET.V cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -258906.00
BMET.V income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 34435.00
BMET.V balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 4199614.00
BMET.V income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 241029.00
BMET.V income_statement (quarterly, 2026-03-31) — Interest Expense: 0.00
BMET.V income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 0.00
BMET.V income_statement (quarterly, 2026-03-31) — Interest Income: 11034.00
BMET.V income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 11034.00
BMET.V balance_sheet (quarterly, 2026-03-31) — Invested Capital: 6418511.00
BMET.V cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -36403.00
BMET.V cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 3513.00
BMET.V income_statement (quarterly, 2026-03-31) — Net Income: -258021.00
BMET.V income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -258021.00
BMET.V income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -258022.00
BMET.V income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -258021.00
BMET.V income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -258021.00
BMET.V cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -258021.00
BMET.V income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -258022.00
BMET.V income_statement (quarterly, 2026-03-31) — Net Interest Income: 11034.00
BMET.V income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 11034.00
BMET.V cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -36403.00
BMET.V balance_sheet (quarterly, 2026-03-31) — Net PPE: 4896428.00
BMET.V cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: 0.00
BMET.V balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 6418511.00
BMET.V income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -292457.00
BMET.V income_statement (quarterly, 2026-03-31) — Normalized Income: -292456.00
BMET.V cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -258906.00
BMET.V cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 3513.00
BMET.V income_statement (quarterly, 2026-03-31) — Operating Income: -335350.00
BMET.V income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
BMET.V balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 29442363.00
BMET.V balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 4199614.00
BMET.V income_statement (quarterly, 2026-03-31) — Other Gand A: 140419.00
BMET.V income_statement (quarterly, 2026-03-31) — Other Income Expense: 66294.00
BMET.V income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 31859.00
BMET.V income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 80028.00
BMET.V balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 46000.00
BMET.V balance_sheet (quarterly, 2026-03-31) — Payables: 179058.00
BMET.V balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 179058.00
BMET.V balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 37705.00
BMET.V income_statement (quarterly, 2026-03-31) — Pretax Income: -258022.00
BMET.V balance_sheet (quarterly, 2026-03-31) — Receivables: 32717.00
BMET.V balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -53104972.00
BMET.V income_statement (quarterly, 2026-03-31) — Salaries And Wages: 100610.00
BMET.V cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 0.00
BMET.V income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 14293.00
BMET.V income_statement (quarterly, 2026-03-31) — Selling General And Administration: 255322.00
BMET.V balance_sheet (quarterly, 2026-03-31) — Share Issued: 29442363.00